David E.I. Pyott

<b>DAVID E.I. PYOTT: </b>Allergan Chief Executive David E.I. Pyott said the FDA review was routine and was met by scant concern among the small community of specialists who treat children with cerebral palsy. Only one called Allergan on Friday, he said. "There is no concern within the neurological community," Pyott said.

Mark Boster / Los Angeles Times /

DAVID E.I. PYOTT: Allergan Chief Executive David E.I. Pyott said the FDA review was routine and was met by scant concern among the small community of specialists who treat children with cerebral palsy. Only one called Allergan on Friday, he said. "There is no concern within the neurological community," Pyott said.

  • Email E-mail
  • add to Digg Digg
  • add to Twitter Twitter
  • add to Facebook Facebook
  • add to StumbleUpon StumbleUpon
as of 03:17PM ET 11/16/2009
DJIA
10385.88
+115.41
11/16/2009 3:17:00 PM
NASDAQ
2195.32
+27.44
11/16/2009 3:17:00 PM
S&P500
1107.34
+13.86
11/16/2009 3:22:00 PM
QUOTE:
Advertisement
The Latest | news as it happens

 
Gadget Guide »
Tech reviews and news from Times partner IDG.
Verizon Droid: No iPhone killer
• In-flight entertainment on a netbook
• Acer Aspire swivel screen due soon
• FlickTunes for iPhone

Mexico Under Siege »
The drug war at our doorstep.